The Cancer Institute of New Jersey Brings Advanced Breast Surgery to Hamilton
Two leading breast surgical oncologists at The Cancer Institute of New Jersey (CINJ) have joined the breast care team at CINJ Hamilton, the cancer center at Robert Wood Johnson University Hospital Hamilton, providing advanced surgical care for patients with breast cancer.
CINJ’s Director of Breast Care Services Thomas Kearney, MD, FACS, of Princeton, and Laurie J. Kirstein, MD, FACS, of Montgomery, have expanded their practice to Hamilton in addition to their New Brunswick location. Both are faculty at UMDNJ-Robert Wood Johnson Medical School.
“The surgical practice, clinical research emphasis, teaching and leadership provided by Drs. Kearney and Kirstein at The Cancer Institute of New Jersey have contributed to our institution’s success. I am certain their expertise in these areas will provide great benefit to CINJ Hamilton and the patients in the five-county area it serves,” says CINJ’s chief medical officer Deborah Toppmeyer, MD, also a leading breast cancer specialist.
“Community hospitals typically cannot recruit specialists with the experience and credentials of these surgeons, but the special partnership between the Robert Wood Johnson Health System and The Cancer Institute of New Jersey continues to elevate our cancer program,” adds RWJ Hamilton President and CEO Skip Cimino. “As New Jersey’s only Comprehensive Cancer Center designated by the National Cancer Institute, CINJ plays a critical role in New Jersey and the field of cancer research. Some people probably do not realize that the physicians at CINJ Hamilton – including experts in radiation oncology, medical oncology and pathology – come from CINJ and the Robert Wood Johnson Medical School, so our patients are extremely well served.”
As part of a larger team that includes radiation oncologists, medical oncologists, nurse navigators and other professionals, Drs. Kearney and Kirstein help patients select therapies for breast cancer that are most appropriate for them. “Our expertise and counsel are available at any time throughout the journey,” says Dr. Kearney. “As soon as someone has a breast concern, from a newly discovered lump or an abnormal mammogram to a cancer that has already been diagnosed, we address the potential diagnosis and work with our comprehensive team of experts to provide patients with the education they need to make informed decisions. Some of these discussions include information about risk of cancer recurrence, genetics, and clinical trial offerings.
Drs. Kearney and Kirstein each have a significant research portfolio, and both are involved in clinical trials. Their research has appeared in leading medical journals. Dr. Kearney’s research “Communication Participation Behavior during the Delivery of Breast Cancer Care,” is being published next month in The Journal of Clinical Oncology. The project was funded by the National Institutes of Health - National Cancer Institute. Dr. Kirstein is the lead author of research published in the Journal of the American College of Surgeons, “Outcome of Multiple Wire Localization for Larger Breast Cancers: When Can Mastectomy Be Avoided?”
Thomas Kearney, MD, FACS, is the Director of Breast Care Services at CINJ. He completed a fellowship in surgical oncology at The University of Chicago and a surgical residency at Cedars-Sinai Medical Center in Los Angeles. Dr. Kearney is an Associate Professor of Surgery at UMDNJ-Robert Wood Johnson Medical School.
Laurie J. Kirstein, MD, FACS, is the Director of the Breast Fellowship Program at CINJ. She completed fellowship training in breast surgical oncology at the Harvard Massachusetts General Hospital/ Dana Farber Cancer Center /Brigham and Women’s Hospital and a surgical residency at Albert Einstein College of Medicine/Montefiore Medical Center. Dr. Kirstein is an Assistant Professor of Surgery at UMDNJ-Robert Wood Johnson Medical School.